Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Net Sales to Third Parties: $54,532M in FY2025, up 8.4% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Total net sales to third parties | 54 532 | 50 317 | 8 | 8”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Novartis core revenue metric (Innovative Medicines continuing operations) is completely missing from the financial statements
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Sales to Third Parties ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54,532 | +8.4% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 50,317 | +10.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 45,440 | +7.7% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 42,206 | -18.2% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 51,626 | +6.1% | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 48,659 | +2.4% | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2019 | Dec 31, 2019 | 47,498 | +5.9% | Novartis Form 6-K (0001370368-21-000008) ↗ |
| FY2018 | Dec 31, 2018 | 44,833 | -8.7% | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2017 | Dec 31, 2017 | 49,109 | +1.2% | Novartis Form 6-K (0001370368-19-000006) ↗ |
| FY2016 | Dec 31, 2016 | 48,518 | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Breakdown
What makes up net Sales to Third Parties
- Net Sales YoY Growth Drivers Bridge (% cc, % USD & percentage point contribution)8.0% · FY2025
- Top 20 Brands Total44,513 · FY2025
- Rest of Portfolio10,019 · FY2025
- 1. Oncology16,830 · FY2025
- 2. Immunology10,293 · FY2025
- 3. Neuroscience5,993 · FY2025
- 4. Cardiovascular, Renal & Metabolic8,959 · FY2025
- 5. Established Brands & Contract Manufacturing12,457 · FY2025
Cite this data
StockData. (2026). Novartis Net Sales to Third Parties ($M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-net-sales-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.